IRWD
Ironwood Pharmaceuticals, Inc. - Class A
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
IRWD Stock Analysis: Buy, Sell, or Hold?
$4.85
-0.02 (-0.41%)
▼
5d:
+20.35%
30d:
+34.72%
90d:
+12.53%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (19%)
Quality Score
38/100
Position
EXTENDED
30-Day Fair Range
$3.38 – $4.26
Position: EXTENDED
Forward P/E & Valuation
3.2x
FAIR
vs 3.5x historical avg
Wall Street Target
$6.10
+25.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.40 / $5.00
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: IRWD is 13.8% above its trading range ($4.26). Market expects -2.7% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When IRWD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.01
Based on 14.0% avg growth
INTRINSIC VALUE TODAY
$6.22
22.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRWD is currently trading at $4.85, which is considered extended relative to its 30-day fair value range of $3.38 to $4.26. The stock's valuation (Forward PE: 3.2) is in line with its historical norms (3.5). Remarkably, the market is currently pricing in an annual earnings decline of 2.7% over the next few years. This pessimistic expectation contrasts with the company's recent 57.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, IRWD is in a strong uptrend. The price is approaching resistance at $5.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IRWD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.10 (+25.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IRWD is in a strong uptrend. The price is approaching resistance at $5.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IRWD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.10 (+25.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.38 -
$4.26
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
19.0%
Trading Range & Key Levels
30-Day Trading Range
$3.38 -
$4.26
Current vs Trading Range
EXTENDED
Support Level
$3.40
Resistance Level
$5.00
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+13.8% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.8% below Wall St target ($6.10)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
3.23
Wall Street Target
$6.10
(+25.8%)
Revenue Growth (YoY)
9.0%
Earnings Growth (YoY)
57.0%
Profit Margin
37.4%
Valuation Discount vs History
-2.7% cheaper
PE vs Historical
3.2 vs 3.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.7%
(market-implied from PE analysis)
1-Year Target
$4.72
(-3%)
2-Year Target
$4.59
(-5%)
3-Year Target
$4.47
(-8%)
3-Yr Target (if PE normalizes)
(PE: 3→4)
$4.84
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 24.0%)
$56.75
(+1070%)
Base:
(SPY PE: 3.2, Growth: 24.0%)
$9.24
(+91%)
Bear:
(PE: 2.7, Growth: 24.0%)
$7.85
(+62%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (5x PE), but valuation improves significantly next year (3x PE) as earnings recover.
Trailing PE: 5.41 | Current EPS (TTM): $0.90
Bull Case
$8.93
(+84%)
Analyst growth 66.7%, PE expands to 6.0
Base Case
$8.12
(+67%)
Market implied 66.7%, PE stable at 5.4
Bear Case
$3.31
(-32%)
Severe decline -20.0%, PE contracts to 4.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.2 to 3.5
Stabilization Target:
$5.25
(+8.2%)
PE Expansion Potential:
+8.2%
Share IRWD Analysis
Share this live IRWD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IRWD)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
Ironwood Pharmaceuticals beat earnings expectations, posting an EPS of $0.57 versus $0.49 estimated.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 4:57 AM ET
Data refreshes hourly during market hours. Next update: 5:57 AM
Data refreshes hourly during market hours. Next update: 5:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRWD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 36 SELL |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IRWD Research Pages
